This study is not accepting new patients
Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study started
- Principal Investigator
- by Mykola Onyshchenko
Description
Summary
Details
Keywords
Eligibility
Locations
Lead Scientist at UCLA
Details
- Status
- not accepting new patients
- Start Date
- Sponsor
- Loxo Oncology, Inc.
- ID
- NCT03906331
- Study Type
- Expanded Access
- Last Updated